CSI Market
Sign In | Register

Viropharma Inc (VPHM) Annual Income Statement

Annual · GAAP · USD millions
Access VPHM quarterly income statements →
Quarterly income statement trends provide context on Viropharma Inc's margins, operating leverage, and earnings trajectory.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2012)
2012 		(Dec 31 2009)
Revenues
Sales Revenue, Goods, Net427.93
Total Revenue427.93
Costs & Expenses
Cost of Goods and Services Sold108.55
Gross Profit319.39
Selling, Administration, Marketing174.32
Depreciation & Amortization35.30
Research and Development Expense67.71
Restructuring, Accretion & Impairment Charges0.00
Other Operating Expense / -Income8.72
Total operating costs including COS394.59
Operating income / -loss33.34
Interest Expense14.09
Net Interest (-)Expense / Income-14.09
Extinguishment of Debt0.00
Investment Income, Interest0.00
Other loss / -income0.23
Total costs & expenses408.91
Income & Taxes
Income / -loss before income taxes19.02
Income taxes expenses / -benefit13.41
Income after income taxes5.61
Net income / -loss of other equity0.00
Income / -loss from continuing operations5.61
Net income / -loss5.61
Income / -loss to shareholder5.61
EBIT33.11
EBITD61.67
EBITDA80.42
Earnings Per Share
Basic EPS (excl. extra items)8.00
Basic Net EPS8.00
Basic shares outstanding (Mill. of Units)68.21
Diluted Net EPS8.00
Diluted average shares (Mill. of Units)71.76
4 historic quarters locked

Sign in to unlock the full Viropharma Inc income statement history.

Sign In Create Free Account

About VPHM Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.